Loading…
Transfemoral trans-facial vein-superior ophthalmic vein to embolize cavernous sinus dural arteriovenous fistulas
Cavernous sinus dural arteriovenous fistula (CS-DAVF) is an abnormal communication between the CS and dural arteries from the internal carotid artery and external carotid artery. CS-DAVFs are not uncommon. The preferred treatment for most CS-DAVFs is transvenous embolization (TVE), which can achieve...
Saved in:
Published in: | Frontiers in neurology 2023-01, Vol.13, p.1078185 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c468t-7de2303dfbcbd1d32f5af5be705b696149a828ac9c10ddda635c1b586a4f1e4f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c468t-7de2303dfbcbd1d32f5af5be705b696149a828ac9c10ddda635c1b586a4f1e4f3 |
container_end_page | |
container_issue | |
container_start_page | 1078185 |
container_title | Frontiers in neurology |
container_volume | 13 |
creator | Zhou, Zibo Xu, Kan Yu, Jinlu |
description | Cavernous sinus dural arteriovenous fistula (CS-DAVF) is an abnormal communication between the CS and dural arteries from the internal carotid artery and external carotid artery. CS-DAVFs are not uncommon. The preferred treatment for most CS-DAVFs is transvenous embolization (TVE), which can achieve a high cure rate with few complications. The trans-inferior petrous sinus (IPS) route from the internal jugular vein to the CS is the favorite and most direct route to perform TVE in the great majority of CS-DAVFs. However, when the trans-IPS route fails and if the facial vein (FV) is patent and dilated, transfemoral trans-FV-superior ophthalmic vein (SOV) embolization of the CS-DAVF can be attempted. However, the transfemoral trans-FV-SOV route to embolize CS-DAVFs is often challenging, and there is insufficient knowledge about it. Therefore, an updated review of the transfemoral trans-FV-SOV route to embolize CS-DAVFs is necessary, and this review includes our experience. The images in this review are from our institute without the dispute of copyright. Issues regarding the transfemoral trans-FV-SOV route to embolize CS-DAV were discussed, including the FV anatomy and variation, various TVE routes to access CS-DAVF, the procedure of the transfemoral trans-FV-SOV route to embolize CS-DAVF, difficulty, and solution of the transfemoral trans-FV-SOV route to embolize CS-DAVF, and complications and prognosis of transfemoral trans-FV-SOV to embolize CS-DAVF. By reviewing the transfemoral trans-FV-SOV route to embolize CS-DAVFs, we found that this route provides a valuable alternative to the other transvenous routes. A good prognosis can be obtained with the transfemoral trans-FV-SOV route to embolize CS-DAVFs in select cases. |
doi_str_mv | 10.3389/fneur.2022.1078185 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_96b9e1152cbe41a399065d7005f1c9c1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_96b9e1152cbe41a399065d7005f1c9c1</doaj_id><sourcerecordid>2771085176</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-7de2303dfbcbd1d32f5af5be705b696149a828ac9c10ddda635c1b586a4f1e4f3</originalsourceid><addsrcrecordid>eNpVkUtv1DAQxyMEolXpF-CAcuSSxY_4dUFCFY9KlbiUs-XHuOsqiYOdrASfHmd3qVof7BnPzG9G82-a9xjtKJXqU5hgzTuCCNlhJCSW7FVziTnvO0IUe_3MvmiuS3lE9VClKKdvmwvKBSY95pfNfJ_NVAKMKZuhXTanC8bF6hwgTl1ZZ8gx5TbN-2VvhjG6Y6BdUgujTUP8C60zB8hTWktb4lRvv24wk5et9ADHSIhlWQdT3jVvghkKXJ_fq-bXt6_3Nz-6u5_fb2--3HWu53LphAdCEfXBOuuxpyQwE5gFgZjliuNeGUmkccph5L03nDKHLZPc9AFDH-hVc3vi-mQe9ZzjaPIfnUzUx4-UH3QdMLoBtOJWAcaMOAs9NnVLiDMvEGIBbw0q6_OJNa92BO9gqosaXkBfRqa41w_poJUUghFWAR_PgJx-r1AWPcbiYBjMBHU5mgiBkWRY8JpKTqkup1IyhKc2GOlNeX1UXm_K67PytejD8wGfSv7rTP8B1JuvTQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2771085176</pqid></control><display><type>article</type><title>Transfemoral trans-facial vein-superior ophthalmic vein to embolize cavernous sinus dural arteriovenous fistulas</title><source>Open Access: PubMed Central</source><creator>Zhou, Zibo ; Xu, Kan ; Yu, Jinlu</creator><creatorcontrib>Zhou, Zibo ; Xu, Kan ; Yu, Jinlu</creatorcontrib><description>Cavernous sinus dural arteriovenous fistula (CS-DAVF) is an abnormal communication between the CS and dural arteries from the internal carotid artery and external carotid artery. CS-DAVFs are not uncommon. The preferred treatment for most CS-DAVFs is transvenous embolization (TVE), which can achieve a high cure rate with few complications. The trans-inferior petrous sinus (IPS) route from the internal jugular vein to the CS is the favorite and most direct route to perform TVE in the great majority of CS-DAVFs. However, when the trans-IPS route fails and if the facial vein (FV) is patent and dilated, transfemoral trans-FV-superior ophthalmic vein (SOV) embolization of the CS-DAVF can be attempted. However, the transfemoral trans-FV-SOV route to embolize CS-DAVFs is often challenging, and there is insufficient knowledge about it. Therefore, an updated review of the transfemoral trans-FV-SOV route to embolize CS-DAVFs is necessary, and this review includes our experience. The images in this review are from our institute without the dispute of copyright. Issues regarding the transfemoral trans-FV-SOV route to embolize CS-DAV were discussed, including the FV anatomy and variation, various TVE routes to access CS-DAVF, the procedure of the transfemoral trans-FV-SOV route to embolize CS-DAVF, difficulty, and solution of the transfemoral trans-FV-SOV route to embolize CS-DAVF, and complications and prognosis of transfemoral trans-FV-SOV to embolize CS-DAVF. By reviewing the transfemoral trans-FV-SOV route to embolize CS-DAVFs, we found that this route provides a valuable alternative to the other transvenous routes. A good prognosis can be obtained with the transfemoral trans-FV-SOV route to embolize CS-DAVFs in select cases.</description><identifier>ISSN: 1664-2295</identifier><identifier>EISSN: 1664-2295</identifier><identifier>DOI: 10.3389/fneur.2022.1078185</identifier><identifier>PMID: 36712416</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>cavernous sinus ; dural arteriovenous fistula ; embolization ; facial vein ; Neurology ; review</subject><ispartof>Frontiers in neurology, 2023-01, Vol.13, p.1078185</ispartof><rights>Copyright © 2023 Zhou, Xu and Yu.</rights><rights>Copyright © 2023 Zhou, Xu and Yu. 2023 Zhou, Xu and Yu</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-7de2303dfbcbd1d32f5af5be705b696149a828ac9c10ddda635c1b586a4f1e4f3</citedby><cites>FETCH-LOGICAL-c468t-7de2303dfbcbd1d32f5af5be705b696149a828ac9c10ddda635c1b586a4f1e4f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877525/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877525/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36712416$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhou, Zibo</creatorcontrib><creatorcontrib>Xu, Kan</creatorcontrib><creatorcontrib>Yu, Jinlu</creatorcontrib><title>Transfemoral trans-facial vein-superior ophthalmic vein to embolize cavernous sinus dural arteriovenous fistulas</title><title>Frontiers in neurology</title><addtitle>Front Neurol</addtitle><description>Cavernous sinus dural arteriovenous fistula (CS-DAVF) is an abnormal communication between the CS and dural arteries from the internal carotid artery and external carotid artery. CS-DAVFs are not uncommon. The preferred treatment for most CS-DAVFs is transvenous embolization (TVE), which can achieve a high cure rate with few complications. The trans-inferior petrous sinus (IPS) route from the internal jugular vein to the CS is the favorite and most direct route to perform TVE in the great majority of CS-DAVFs. However, when the trans-IPS route fails and if the facial vein (FV) is patent and dilated, transfemoral trans-FV-superior ophthalmic vein (SOV) embolization of the CS-DAVF can be attempted. However, the transfemoral trans-FV-SOV route to embolize CS-DAVFs is often challenging, and there is insufficient knowledge about it. Therefore, an updated review of the transfemoral trans-FV-SOV route to embolize CS-DAVFs is necessary, and this review includes our experience. The images in this review are from our institute without the dispute of copyright. Issues regarding the transfemoral trans-FV-SOV route to embolize CS-DAV were discussed, including the FV anatomy and variation, various TVE routes to access CS-DAVF, the procedure of the transfemoral trans-FV-SOV route to embolize CS-DAVF, difficulty, and solution of the transfemoral trans-FV-SOV route to embolize CS-DAVF, and complications and prognosis of transfemoral trans-FV-SOV to embolize CS-DAVF. By reviewing the transfemoral trans-FV-SOV route to embolize CS-DAVFs, we found that this route provides a valuable alternative to the other transvenous routes. A good prognosis can be obtained with the transfemoral trans-FV-SOV route to embolize CS-DAVFs in select cases.</description><subject>cavernous sinus</subject><subject>dural arteriovenous fistula</subject><subject>embolization</subject><subject>facial vein</subject><subject>Neurology</subject><subject>review</subject><issn>1664-2295</issn><issn>1664-2295</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkUtv1DAQxyMEolXpF-CAcuSSxY_4dUFCFY9KlbiUs-XHuOsqiYOdrASfHmd3qVof7BnPzG9G82-a9xjtKJXqU5hgzTuCCNlhJCSW7FVziTnvO0IUe_3MvmiuS3lE9VClKKdvmwvKBSY95pfNfJ_NVAKMKZuhXTanC8bF6hwgTl1ZZ8gx5TbN-2VvhjG6Y6BdUgujTUP8C60zB8hTWktb4lRvv24wk5et9ADHSIhlWQdT3jVvghkKXJ_fq-bXt6_3Nz-6u5_fb2--3HWu53LphAdCEfXBOuuxpyQwE5gFgZjliuNeGUmkccph5L03nDKHLZPc9AFDH-hVc3vi-mQe9ZzjaPIfnUzUx4-UH3QdMLoBtOJWAcaMOAs9NnVLiDMvEGIBbw0q6_OJNa92BO9gqosaXkBfRqa41w_poJUUghFWAR_PgJx-r1AWPcbiYBjMBHU5mgiBkWRY8JpKTqkup1IyhKc2GOlNeX1UXm_K67PytejD8wGfSv7rTP8B1JuvTQ</recordid><startdate>20230112</startdate><enddate>20230112</enddate><creator>Zhou, Zibo</creator><creator>Xu, Kan</creator><creator>Yu, Jinlu</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230112</creationdate><title>Transfemoral trans-facial vein-superior ophthalmic vein to embolize cavernous sinus dural arteriovenous fistulas</title><author>Zhou, Zibo ; Xu, Kan ; Yu, Jinlu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-7de2303dfbcbd1d32f5af5be705b696149a828ac9c10ddda635c1b586a4f1e4f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>cavernous sinus</topic><topic>dural arteriovenous fistula</topic><topic>embolization</topic><topic>facial vein</topic><topic>Neurology</topic><topic>review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhou, Zibo</creatorcontrib><creatorcontrib>Xu, Kan</creatorcontrib><creatorcontrib>Yu, Jinlu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Frontiers in neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, Zibo</au><au>Xu, Kan</au><au>Yu, Jinlu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transfemoral trans-facial vein-superior ophthalmic vein to embolize cavernous sinus dural arteriovenous fistulas</atitle><jtitle>Frontiers in neurology</jtitle><addtitle>Front Neurol</addtitle><date>2023-01-12</date><risdate>2023</risdate><volume>13</volume><spage>1078185</spage><pages>1078185-</pages><issn>1664-2295</issn><eissn>1664-2295</eissn><abstract>Cavernous sinus dural arteriovenous fistula (CS-DAVF) is an abnormal communication between the CS and dural arteries from the internal carotid artery and external carotid artery. CS-DAVFs are not uncommon. The preferred treatment for most CS-DAVFs is transvenous embolization (TVE), which can achieve a high cure rate with few complications. The trans-inferior petrous sinus (IPS) route from the internal jugular vein to the CS is the favorite and most direct route to perform TVE in the great majority of CS-DAVFs. However, when the trans-IPS route fails and if the facial vein (FV) is patent and dilated, transfemoral trans-FV-superior ophthalmic vein (SOV) embolization of the CS-DAVF can be attempted. However, the transfemoral trans-FV-SOV route to embolize CS-DAVFs is often challenging, and there is insufficient knowledge about it. Therefore, an updated review of the transfemoral trans-FV-SOV route to embolize CS-DAVFs is necessary, and this review includes our experience. The images in this review are from our institute without the dispute of copyright. Issues regarding the transfemoral trans-FV-SOV route to embolize CS-DAV were discussed, including the FV anatomy and variation, various TVE routes to access CS-DAVF, the procedure of the transfemoral trans-FV-SOV route to embolize CS-DAVF, difficulty, and solution of the transfemoral trans-FV-SOV route to embolize CS-DAVF, and complications and prognosis of transfemoral trans-FV-SOV to embolize CS-DAVF. By reviewing the transfemoral trans-FV-SOV route to embolize CS-DAVFs, we found that this route provides a valuable alternative to the other transvenous routes. A good prognosis can be obtained with the transfemoral trans-FV-SOV route to embolize CS-DAVFs in select cases.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>36712416</pmid><doi>10.3389/fneur.2022.1078185</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1664-2295 |
ispartof | Frontiers in neurology, 2023-01, Vol.13, p.1078185 |
issn | 1664-2295 1664-2295 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_96b9e1152cbe41a399065d7005f1c9c1 |
source | Open Access: PubMed Central |
subjects | cavernous sinus dural arteriovenous fistula embolization facial vein Neurology review |
title | Transfemoral trans-facial vein-superior ophthalmic vein to embolize cavernous sinus dural arteriovenous fistulas |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T00%3A28%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transfemoral%20trans-facial%20vein-superior%20ophthalmic%20vein%20to%20embolize%20cavernous%20sinus%20dural%20arteriovenous%20fistulas&rft.jtitle=Frontiers%20in%20neurology&rft.au=Zhou,%20Zibo&rft.date=2023-01-12&rft.volume=13&rft.spage=1078185&rft.pages=1078185-&rft.issn=1664-2295&rft.eissn=1664-2295&rft_id=info:doi/10.3389/fneur.2022.1078185&rft_dat=%3Cproquest_doaj_%3E2771085176%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c468t-7de2303dfbcbd1d32f5af5be705b696149a828ac9c10ddda635c1b586a4f1e4f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2771085176&rft_id=info:pmid/36712416&rfr_iscdi=true |